ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.
The key factors assisting the growth of instruments and assay systems market are enhanced accuracy and predictability of ADME –Tox technology, market shift towards in-vitro assays for toxicological studies and increasing global adoption of novel ADME toxicology testing instruments and assay systems.

Market Analysis and Insights: Global ADME-Toxicology Testing Market
The global ADME-Toxicology Testing market size is projected to reach US$ 4909.8 million by 2026, from US$ 4464.2 million in 2020, at a CAGR of 9.2%% during 2021-2026.

Global ADME-Toxicology Testing Scope and Market Size
ADME-Toxicology Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global ADME-Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Accelrys (Dassault Systemes)
Agilent Technologies
Bio-Rad Laboratories
Promega
Sigma Aldrich
Thermo Fisher Scientific
Cyprtorex
CytoPulse
Entelos
LI-COR Biosciences
Mattek
Miltenyi Biotec
Molecular Toxicology
Quintiles
RTI Health Solutions
SBW
Xenobiotic Detection Systems
Xenometrix

Market segment by Type, the product can be split into

In-vitro Testing
Biochemical Testing
Cell Testing
In-vivo Testing

Market segment by Application, split into

Laboratories
Pharmaceutical
Medical
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India